Autonomix Medical Common Stock Statistics
Share Statistics
Autonomix Medical Common Stock has 1.77M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 1.77M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 126.50K |
FTD / Avg. Volume | 23.49% |
Short Selling Information
The latest short interest is 100.15K, so 8.69% of the outstanding shares have been sold short.
Short Interest | 100.15K |
Short % of Shares Out | 8.69% |
Short % of Float | 15.97% |
Short Ratio (days to cover) | 0.09 |
Valuation Ratios
The PE ratio is -2.84 and the forward PE ratio is -1.43.
PE Ratio | -2.84 |
Forward PE | -1.43 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 5.75 |
P/FCF Ratio | -6.58 |
PEG Ratio | n/a |
Enterprise Valuation
Autonomix Medical Inc. Common Stock has an Enterprise Value (EV) of -.
EV / Earnings | null |
EV / Sales | null |
EV / EBITDA | null |
EV / EBIT | null |
EV / FCF | null |
Financial Position
The company has a current ratio of 12.09, with a Debt / Equity ratio of 0.13.
Current Ratio | 12.09 |
Quick Ratio | 12.09 |
Debt / Equity | 0.13 |
Total Debt / Capitalization | 11.61 |
Cash Flow / Debt | -6.63 |
Interest Coverage | -94.61 |
Financial Efficiency
Return on equity (ROE) is -2.02% and return on capital (ROIC) is -86.6%.
Return on Equity (ROE) | -2.02% |
Return on Assets (ROA) | -1.64% |
Return on Capital (ROIC) | -86.6% |
Revenue Per Employee | 0 |
Profits Per Employee | -3.09M |
Employee Count | 5 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Autonomix Medical Common Stock's price volatility has been lower than the market average.
Beta | 0 |
52-Week Price Change | null% |
50-Day Moving Average | 9.49 |
200-Day Moving Average | 29.19 |
Relative Strength Index (RSI) | 28.79 |
Average Volume (20 Days) | 538.52K |
Income Statement
In the last 12 months, Autonomix Medical Common Stock had revenue of $0 and earned -$15.43M in profits. Earnings per share was $-21.1.
Revenue | 0 |
Gross Profit | -81.00K |
Operating Income | -7.47M |
Net Income | -15.43M |
EBITDA | -15.27M |
EBIT | - |
Earnings Per Share (EPS) | -21.1 |
Balance Sheet
The company has $8.61M in cash and $1.00M in debt, giving a net cash position of $7.61M.
Cash & Cash Equivalents | 8.61M |
Total Debt | 1.00M |
Net Cash | 7.61M |
Retained Earnings | -38.97M |
Total Assets | 5.37M |
Working Capital | 4.10M |
Cash Flow
In the last 12 months, operating cash flow was -$6.65M and capital expenditures -$19.00K, giving a free cash flow of -$6.67M.
Operating Cash Flow | -6.65M |
Capital Expenditures | -19.00K |
Free Cash Flow | -6.67M |
FCF Per Share | -9.12 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
Gross Margin | 0% |
Operating Margin | 0% |
Pretax Margin | 0% |
Profit Margin | 0% |
EBITDA Margin | n/a% |
EBIT Margin | n/a% |
FCF Margin | n/a% |
Dividends & Yields
AMIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -653.25% |
FCF Yield | -116.77% |
Analyst Forecast
Currently there are no analyst rating for AMIX.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -17.77 |
Piotroski F-Score | 2 |